UPS
48
5
FIS
55
2
AMGN
39
6
LEN
61
2
UNP
55
2
FMC
39
3
AES
37
4
D
51
10
FDX
34
7
MPC
34
4
CPB
40
-2
CMI
54
3
TGT
50
-2
GME
55
3
SLB
52
6
ORCL
65
2
PPL
60
3
RHI
53
3
CNP
65
3
JCI
54
2
UPS
48
5
FIS
55
2
AMGN
39
6
LEN
61
2
UNP
55
2
FMC
39
3
AES
37
4
D
51
10
FDX
34
7
MPC
34
4
CPB
40
-2
CMI
54
3
TGT
50
-2
GME
55
3
SLB
52
6
ORCL
65
2
PPL
60
3
RHI
53
3
CNP
65
3
JCI
54
2
Financhill
Back

Berkshire Hathaway Vs. Kymera Therapeutics Industry Stock Comparison

Sell
49

BRK.A
Berkshire Hathaway

Last Price:
698,090.01
Seasonality Move:
4.81%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%
Sell
49
Berkshire Hathaway (BRK.A) is a Sell

Is Berkshire Hathaway a Buy, Sell or Hold?

  • The current Berkshire Hathaway [BRK.A] share price is $699,413.00. The Score for BRK.A is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • BRK.A is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BRK.A Stock Price Chart

What is Berkshire Hathaway's stock price today?

  • The Berkshire Hathaway share price today is $699,413.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BRK.A is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

BRK.A Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2821.6 Buy
Relative Strength Index (14 RSI): 59.72 Buy
Chaikin Money Flow: 1197 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (684632.47 - 684644.47) Buy
Bollinger Bands (100): (655321.85 - 655383.85) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

BRK.A Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 686674.69 Buy
20-day SMA: 685949.59 Buy
50-day SMA: 681313.95 Buy
200-day SMA: 628960.97 Buy
8-day EMA: 689681.47 Buy
20-day EMA: 686636.88 Buy
50-day EMA: 677881.99 Buy
200-day EMA: 630767.16 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

Berkshire Hathaway Earnings Growth & BRK.A Earnings Dates

  • Analysts estimate an earnings increase this quarter of $650.50 per share, a decrease next quarter of $0.00 per share, an increase this year of $6,702.01 per share, and an increase next year of $175.97 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

Berkshire Hathaway Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):